secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELECT MEDICAL HOLDINGS CORP (SEM)
CIK:        0001320414
Form:       8-K
Filed at:   2023-07-19T23:59:59+00:00
Accession:  0001104659-23-082364
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Select Medical Q2 estimates: revenue ~$1.67B, Adj EBITDA ~$219M, EPS ~$0.61; in refinancing talks
--------------------------------------------------------------------------------

- Net operating revenue expected ~$1.67B for Q2 ended June 30, 2023.
- Adjusted EBITDA ~$219M; fully diluted EPS ~$0.61.
- As of June 30, 2023, cash ~$100M; indebtedness ~$3.75B.
- Company in discussions with lenders regarding proposed refinancing of certain debt.
- Actual Q2 results to be announced after market close on August 3, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1320414/000110465923082364/0001104659-23-082364-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1320414/000110465923082364/tm2321598d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-082364

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer